Trial Site Detail
Drug: |
CB-839 + Talazoparib |
|||
|---|---|---|---|---|
Trial: |
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
|||
Huntsman Cancer Institute2000 Circle of Hope |
Principal Investigator: |
Neeraj Agarwal, MD |
|---|---|
Contact: |
Jill Broghammer 801-213-6232 Jill.Broghammer@hci.utah.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Huntsman Cancer Institute Website: |
http://oncore-app1.hci.utah.edu/sip-mobile/flowchart.html |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.